Advertisement
Advertisement
U.S. markets close in 5 hours 30 minutes
Advertisement
Advertisement
Advertisement
Advertisement

BiondVax Pharmaceuticals Ltd. (BVXV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1900+0.0100 (+0.85%)
As of 09:30AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close1.1800
Open1.1900
Bid1.1800 x 1300
Ask1.2000 x 1300
Day's Range1.1900 - 1.1900
52 Week Range1.0000 - 3.4900
Volume156
Avg. Volume34,141
Market Cap22.165M
Beta (5Y Monthly)2.36
PE Ratio (TTM)N/A
EPS (TTM)-2.2960
Earnings DateMay 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BVXV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BiondVax Pharmaceuticals Ltd.
    CARA: Lowering target price to $11.00CARA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $11.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    9 months agoArgus Research
View more
Advertisement
Advertisement